Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam® (Cholic Acid)

NCT03115086 is registered in ClinicalTrials.gov with Mirum Pharmaceuticals, Inc. as lead sponsor.

NCT NCT03115086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03115086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam® (Cholic Acid)
Lead sponsor
Mirum Pharmaceuticals, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
July 10, 2017
Completion date
July 31, 2039
Enrollment
55 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

bile acid synthesis disorders